HCRN-LUN23-618

Phase II study of adagrasib + stereotactic radiosurgery (SRS) for patients with metastatic KRAS G12C-mutated NSCLC with untreated brain metastases

Status

Currently Enrolling

Cancer Type(s)

Trial Locations

All sites in which the trial HCRN-LUN23-618 being conducted in.